Advaxis, Inc.
Advaxis, Inc. ADXSD Peers
See (ADXSD) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ADXSD | $3.85 | +8.45% | 0 | N/A | N/A | N/A |
| NONOF | $73.47 | -1.84% | 326.1B | 20.30 | $3.62 | +2.26% |
| CSLLY | $78.99 | +1.70% | 153B | 29.04 | $2.72 | +1.68% |
| CMXHF | $148.56 | -1.54% | 71.9B | 27.21 | $5.46 | +1.86% |
| UCBJF | $186.29 | -1.96% | 35.4B | 29.57 | $6.30 | +0.85% |
| ARGNF | $562.00 | -4.18% | 34.3B | 34.23 | $16.42 | N/A |
| BBIXF | $0.05 | +50900.00% | 34B | -5.10 | -$0.01 | N/A |
| UCBJY | $89.37 | -1.20% | 34B | 28.28 | $3.16 | +0.88% |
| ODTC | $22,005.00 | +29.44% | 24.1B | -0.08 | -$268,995.00 | N/A |
| IVBXF | $9.74 | -7.24% | 16.1B | -973.95 | -$0.01 | N/A |
Stock Comparison
ADXSD vs NONOF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, NONOF has a market cap of 326.1B. Regarding current trading prices, ADXSD is priced at $3.85, while NONOF trades at $73.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas NONOF's P/E ratio is 20.30. In terms of profitability, ADXSD's ROE is +121.70%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, ADXSD is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs CSLLY Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, CSLLY has a market cap of 153B. Regarding current trading prices, ADXSD is priced at $3.85, while CSLLY trades at $78.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas CSLLY's P/E ratio is 29.04. In terms of profitability, ADXSD's ROE is +121.70%, compared to CSLLY's ROE of +0.26%. Regarding short-term risk, ADXSD is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs CMXHF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, CMXHF has a market cap of 71.9B. Regarding current trading prices, ADXSD is priced at $3.85, while CMXHF trades at $148.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas CMXHF's P/E ratio is 27.21. In terms of profitability, ADXSD's ROE is +121.70%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, ADXSD is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs UCBJF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, UCBJF has a market cap of 35.4B. Regarding current trading prices, ADXSD is priced at $3.85, while UCBJF trades at $186.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas UCBJF's P/E ratio is 29.57. In terms of profitability, ADXSD's ROE is +121.70%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, ADXSD is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs ARGNF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, ARGNF has a market cap of 34.3B. Regarding current trading prices, ADXSD is priced at $3.85, while ARGNF trades at $562.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas ARGNF's P/E ratio is 34.23. In terms of profitability, ADXSD's ROE is +121.70%, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, ADXSD is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs BBIXF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, BBIXF has a market cap of 34B. Regarding current trading prices, ADXSD is priced at $3.85, while BBIXF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas BBIXF's P/E ratio is -5.10. In terms of profitability, ADXSD's ROE is +121.70%, compared to BBIXF's ROE of -2.10%. Regarding short-term risk, ADXSD is less volatile compared to BBIXF. This indicates potentially lower risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs UCBJY Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, UCBJY has a market cap of 34B. Regarding current trading prices, ADXSD is priced at $3.85, while UCBJY trades at $89.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas UCBJY's P/E ratio is 28.28. In terms of profitability, ADXSD's ROE is +121.70%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, ADXSD is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs ODTC Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, ODTC has a market cap of 24.1B. Regarding current trading prices, ADXSD is priced at $3.85, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas ODTC's P/E ratio is -0.08. In terms of profitability, ADXSD's ROE is +121.70%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, ADXSD is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs IVBXF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, IVBXF has a market cap of 16.1B. Regarding current trading prices, ADXSD is priced at $3.85, while IVBXF trades at $9.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas IVBXF's P/E ratio is -973.95. In terms of profitability, ADXSD's ROE is +121.70%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, ADXSD is less volatile compared to IVBXF. This indicates potentially lower risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs WXIBF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, WXIBF has a market cap of 13.2B. Regarding current trading prices, ADXSD is priced at $3.85, while WXIBF trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas WXIBF's P/E ratio is 32.50. In terms of profitability, ADXSD's ROE is +121.70%, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, ADXSD is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs WXXWY Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, WXXWY has a market cap of 13B. Regarding current trading prices, ADXSD is priced at $3.85, while WXXWY trades at $6.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas WXXWY's P/E ratio is 28.14. In terms of profitability, ADXSD's ROE is +121.70%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, ADXSD is more volatile compared to WXXWY. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs GNMSF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, GNMSF has a market cap of 13B. Regarding current trading prices, ADXSD is priced at $3.85, while GNMSF trades at $211.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas GNMSF's P/E ratio is 12.40. In terms of profitability, ADXSD's ROE is +121.70%, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, ADXSD is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs SBMFF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, SBMFF has a market cap of 11.4B. Regarding current trading prices, ADXSD is priced at $3.85, while SBMFF trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas SBMFF's P/E ratio is 31.86. In terms of profitability, ADXSD's ROE is +121.70%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, ADXSD is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs SBHMY Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, SBHMY has a market cap of 8.7B. Regarding current trading prices, ADXSD is priced at $3.85, while SBHMY trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas SBHMY's P/E ratio is 33.62. In terms of profitability, ADXSD's ROE is +121.70%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, ADXSD is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs TRSBF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, TRSBF has a market cap of 7B. Regarding current trading prices, ADXSD is priced at $3.85, while TRSBF trades at $2.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas TRSBF's P/E ratio is 24.58. In terms of profitability, ADXSD's ROE is +121.70%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, ADXSD is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs TLPPF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, TLPPF has a market cap of 5.5B. Regarding current trading prices, ADXSD is priced at $3.85, while TLPPF trades at $16.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas TLPPF's P/E ratio is 179.56. In terms of profitability, ADXSD's ROE is +121.70%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, ADXSD is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs ABCZF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, ADXSD is priced at $3.85, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, ADXSD's ROE is +121.70%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, ADXSD is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs AKBLF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, AKBLF has a market cap of 5B. Regarding current trading prices, ADXSD is priced at $3.85, while AKBLF trades at $22.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas AKBLF's P/E ratio is 34.38. In terms of profitability, ADXSD's ROE is +121.70%, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, ADXSD is more volatile compared to AKBLF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs INCPF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, INCPF has a market cap of 4.9B. Regarding current trading prices, ADXSD is priced at $3.85, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas INCPF's P/E ratio is -108.67. In terms of profitability, ADXSD's ROE is +121.70%, compared to INCPF's ROE of -0.05%. Regarding short-term risk, ADXSD is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs LABFF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, ADXSD is priced at $3.85, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas LABFF's P/E ratio is 28.95. In terms of profitability, ADXSD's ROE is +121.70%, compared to LABFF's ROE of +0.39%. Regarding short-term risk, ADXSD is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs GNNSF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, GNNSF has a market cap of 4.4B. Regarding current trading prices, ADXSD is priced at $3.85, while GNNSF trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas GNNSF's P/E ratio is -25.62. In terms of profitability, ADXSD's ROE is +121.70%, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, ADXSD is less volatile compared to GNNSF. This indicates potentially lower risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs ZLDPF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, ZLDPF has a market cap of 4.3B. Regarding current trading prices, ADXSD is priced at $3.85, while ZLDPF trades at $60.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas ZLDPF's P/E ratio is -22.39. In terms of profitability, ADXSD's ROE is +121.70%, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, ADXSD is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs CAMRF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, CAMRF has a market cap of 3.7B. Regarding current trading prices, ADXSD is priced at $3.85, while CAMRF trades at $63.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas CAMRF's P/E ratio is 66.32. In terms of profitability, ADXSD's ROE is +121.70%, compared to CAMRF's ROE of +0.14%. Regarding short-term risk, ADXSD is more volatile compared to CAMRF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs REGMF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, REGMF has a market cap of 3.4B. Regarding current trading prices, ADXSD is priced at $3.85, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas REGMF's P/E ratio is -13.32. In terms of profitability, ADXSD's ROE is +121.70%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, ADXSD is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs GLPGF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, GLPGF has a market cap of 3.2B. Regarding current trading prices, ADXSD is priced at $3.85, while GLPGF trades at $48.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas GLPGF's P/E ratio is -15.51. In terms of profitability, ADXSD's ROE is +121.70%, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, ADXSD is less volatile compared to GLPGF. This indicates potentially lower risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs TKBIF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, TKBIF has a market cap of 2.8B. Regarding current trading prices, ADXSD is priced at $3.85, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, ADXSD's ROE is +121.70%, compared to TKBIF's ROE of N/A. Regarding short-term risk, ADXSD is more volatile compared to TKBIF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs MPSYF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, ADXSD is priced at $3.85, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, ADXSD's ROE is +121.70%, compared to MPSYF's ROE of +2.51%. Regarding short-term risk, ADXSD is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs ASPHF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, ASPHF has a market cap of 2.2B. Regarding current trading prices, ADXSD is priced at $3.85, while ASPHF trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas ASPHF's P/E ratio is -35.83. In terms of profitability, ADXSD's ROE is +121.70%, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, ADXSD is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs BVNRY Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, BVNRY has a market cap of 2.1B. Regarding current trading prices, ADXSD is priced at $3.85, while BVNRY trades at $8.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas BVNRY's P/E ratio is 10.46. In terms of profitability, ADXSD's ROE is +121.70%, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, ADXSD is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs BVNKF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, BVNKF has a market cap of 2B. Regarding current trading prices, ADXSD is priced at $3.85, while BVNKF trades at $26.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas BVNKF's P/E ratio is 10.12. In terms of profitability, ADXSD's ROE is +121.70%, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, ADXSD is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs SYGGF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, SYGGF has a market cap of 2B. Regarding current trading prices, ADXSD is priced at $3.85, while SYGGF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas SYGGF's P/E ratio is -0.47. In terms of profitability, ADXSD's ROE is +121.70%, compared to SYGGF's ROE of -0.62%. Regarding short-term risk, ADXSD is more volatile compared to SYGGF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs BTTAY Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, BTTAY has a market cap of 1.9B. Regarding current trading prices, ADXSD is priced at $3.85, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, ADXSD's ROE is +121.70%, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, ADXSD is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs SHJBF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, SHJBF has a market cap of 1.8B. Regarding current trading prices, ADXSD is priced at $3.85, while SHJBF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas SHJBF's P/E ratio is -7.22. In terms of profitability, ADXSD's ROE is +121.70%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, ADXSD is more volatile compared to SHJBF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs BRCTF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, BRCTF has a market cap of 1.8B. Regarding current trading prices, ADXSD is priced at $3.85, while BRCTF trades at $20.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas BRCTF's P/E ratio is 18.89. In terms of profitability, ADXSD's ROE is +121.70%, compared to BRCTF's ROE of -0.19%. Regarding short-term risk, ADXSD is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs GENSF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, GENSF has a market cap of 1.7B. Regarding current trading prices, ADXSD is priced at $3.85, while GENSF trades at $26.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas GENSF's P/E ratio is -289.00. In terms of profitability, ADXSD's ROE is +121.70%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, ADXSD is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs PHMMF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, PHMMF has a market cap of 1.7B. Regarding current trading prices, ADXSD is priced at $3.85, while PHMMF trades at $96.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas PHMMF's P/E ratio is 74.00. In terms of profitability, ADXSD's ROE is +121.70%, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, ADXSD is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs BIESF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, ADXSD is priced at $3.85, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas BIESF's P/E ratio is -44.44. In terms of profitability, ADXSD's ROE is +121.70%, compared to BIESF's ROE of +0.05%. Regarding short-term risk, ADXSD is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs ONTTF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, ONTTF has a market cap of 1.6B. Regarding current trading prices, ADXSD is priced at $3.85, while ONTTF trades at $1.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas ONTTF's P/E ratio is -7.47. In terms of profitability, ADXSD's ROE is +121.70%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, ADXSD is more volatile compared to ONTTF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs PPTDF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, PPTDF has a market cap of 1.4B. Regarding current trading prices, ADXSD is priced at $3.85, while PPTDF trades at $11.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas PPTDF's P/E ratio is 14.05. In terms of profitability, ADXSD's ROE is +121.70%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, ADXSD is more volatile compared to PPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs CSBTF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, CSBTF has a market cap of 1.3B. Regarding current trading prices, ADXSD is priced at $3.85, while CSBTF trades at $32.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas CSBTF's P/E ratio is -271.75. In terms of profitability, ADXSD's ROE is +121.70%, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, ADXSD is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs MEOBF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, MEOBF has a market cap of 1.2B. Regarding current trading prices, ADXSD is priced at $3.85, while MEOBF trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas MEOBF's P/E ratio is -10.72. In terms of profitability, ADXSD's ROE is +121.70%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, ADXSD is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs NURPF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, NURPF has a market cap of 1.1B. Regarding current trading prices, ADXSD is priced at $3.85, while NURPF trades at $8.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas NURPF's P/E ratio is 12.41. In terms of profitability, ADXSD's ROE is +121.70%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, ADXSD is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs SNBIF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, SNBIF has a market cap of 1B. Regarding current trading prices, ADXSD is priced at $3.85, while SNBIF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas SNBIF's P/E ratio is -22.59. In terms of profitability, ADXSD's ROE is +121.70%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, ADXSD is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs ASCLF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, ASCLF has a market cap of 900.1M. Regarding current trading prices, ADXSD is priced at $3.85, while ASCLF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas ASCLF's P/E ratio is -23.21. In terms of profitability, ADXSD's ROE is +121.70%, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, ADXSD is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs PHGUF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, PHGUF has a market cap of 782.4M. Regarding current trading prices, ADXSD is priced at $3.85, while PHGUF trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas PHGUF's P/E ratio is -57.50. In terms of profitability, ADXSD's ROE is +121.70%, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, ADXSD is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs HBMHF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, HBMHF has a market cap of 765.9M. Regarding current trading prices, ADXSD is priced at $3.85, while HBMHF trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas HBMHF's P/E ratio is 30.16. In terms of profitability, ADXSD's ROE is +121.70%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, ADXSD is more volatile compared to HBMHF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs BPMUF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, BPMUF has a market cap of 636.8M. Regarding current trading prices, ADXSD is priced at $3.85, while BPMUF trades at $51.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas BPMUF's P/E ratio is 7.32. In terms of profitability, ADXSD's ROE is +121.70%, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, ADXSD is less volatile compared to BPMUF. This indicates potentially lower risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs INRLF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, INRLF has a market cap of 552.7M. Regarding current trading prices, ADXSD is priced at $3.85, while INRLF trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas INRLF's P/E ratio is -5.08. In terms of profitability, ADXSD's ROE is +121.70%, compared to INRLF's ROE of -0.43%. Regarding short-term risk, ADXSD is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs SOLTF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, SOLTF has a market cap of 533.3M. Regarding current trading prices, ADXSD is priced at $3.85, while SOLTF trades at $5.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas SOLTF's P/E ratio is -32.78. In terms of profitability, ADXSD's ROE is +121.70%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, ADXSD is more volatile compared to SOLTF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs CLAZF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, CLAZF has a market cap of 531.7M. Regarding current trading prices, ADXSD is priced at $3.85, while CLAZF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas CLAZF's P/E ratio is 0.09. In terms of profitability, ADXSD's ROE is +121.70%, compared to CLAZF's ROE of +0.00%. Regarding short-term risk, ADXSD is less volatile compared to CLAZF. This indicates potentially lower risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs IVEVF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, IVEVF has a market cap of 506.3M. Regarding current trading prices, ADXSD is priced at $3.85, while IVEVF trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas IVEVF's P/E ratio is -1.05. In terms of profitability, ADXSD's ROE is +121.70%, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, ADXSD is more volatile compared to IVEVF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs IDRSF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, IDRSF has a market cap of 505.8M. Regarding current trading prices, ADXSD is priced at $3.85, while IDRSF trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas IDRSF's P/E ratio is -1.36. In terms of profitability, ADXSD's ROE is +121.70%, compared to IDRSF's ROE of +0.24%. Regarding short-term risk, ADXSD is more volatile compared to IDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs CLTEF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, CLTEF has a market cap of 504.7M. Regarding current trading prices, ADXSD is priced at $3.85, while CLTEF trades at $7.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas CLTEF's P/E ratio is -7.06. In terms of profitability, ADXSD's ROE is +121.70%, compared to CLTEF's ROE of -0.43%. Regarding short-term risk, ADXSD is more volatile compared to CLTEF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs OXBOF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, OXBOF has a market cap of 489.4M. Regarding current trading prices, ADXSD is priced at $3.85, while OXBOF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas OXBOF's P/E ratio is -4.17. In terms of profitability, ADXSD's ROE is +121.70%, compared to OXBOF's ROE of -2.22%. Regarding short-term risk, ADXSD is less volatile compared to OXBOF. This indicates potentially lower risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs CKDXF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, CKDXF has a market cap of 482.3M. Regarding current trading prices, ADXSD is priced at $3.85, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, ADXSD's ROE is +121.70%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, ADXSD is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs VBIZF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, VBIZF has a market cap of 472.2M. Regarding current trading prices, ADXSD is priced at $3.85, while VBIZF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas VBIZF's P/E ratio is 22.70. In terms of profitability, ADXSD's ROE is +121.70%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, ADXSD is more volatile compared to VBIZF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs MDCLF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, MDCLF has a market cap of 463M. Regarding current trading prices, ADXSD is priced at $3.85, while MDCLF trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas MDCLF's P/E ratio is -10.45. In terms of profitability, ADXSD's ROE is +121.70%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, ADXSD is less volatile compared to MDCLF. This indicates potentially lower risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs AAVXF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, AAVXF has a market cap of 457.4M. Regarding current trading prices, ADXSD is priced at $3.85, while AAVXF trades at $7.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas AAVXF's P/E ratio is -2.14. In terms of profitability, ADXSD's ROE is +121.70%, compared to AAVXF's ROE of -2.11%. Regarding short-term risk, ADXSD is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs RAONF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, ADXSD is priced at $3.85, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas RAONF's P/E ratio is -43.33. In terms of profitability, ADXSD's ROE is +121.70%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, ADXSD is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs BOVNF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, BOVNF has a market cap of 436.3M. Regarding current trading prices, ADXSD is priced at $3.85, while BOVNF trades at $6.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas BOVNF's P/E ratio is -12.05. In terms of profitability, ADXSD's ROE is +121.70%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, ADXSD is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs CSPHF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, CSPHF has a market cap of 435.6M. Regarding current trading prices, ADXSD is priced at $3.85, while CSPHF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas CSPHF's P/E ratio is -32.10. In terms of profitability, ADXSD's ROE is +121.70%, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, ADXSD is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs TBGNF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, ADXSD is priced at $3.85, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, ADXSD's ROE is +121.70%, compared to TBGNF's ROE of N/A. Regarding short-term risk, ADXSD is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs PTCHF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, PTCHF has a market cap of 420.3M. Regarding current trading prices, ADXSD is priced at $3.85, while PTCHF trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas PTCHF's P/E ratio is 8.33. In terms of profitability, ADXSD's ROE is +121.70%, compared to PTCHF's ROE of -0.22%. Regarding short-term risk, ADXSD is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs GSGTF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, GSGTF has a market cap of 403.2M. Regarding current trading prices, ADXSD is priced at $3.85, while GSGTF trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas GSGTF's P/E ratio is -8.16. In terms of profitability, ADXSD's ROE is +121.70%, compared to GSGTF's ROE of +0.78%. Regarding short-term risk, ADXSD is less volatile compared to GSGTF. This indicates potentially lower risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs CYDY Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, CYDY has a market cap of 393M. Regarding current trading prices, ADXSD is priced at $3.85, while CYDY trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas CYDY's P/E ratio is -15.94. In terms of profitability, ADXSD's ROE is +121.70%, compared to CYDY's ROE of +0.07%. Regarding short-term risk, ADXSD is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs BXPHF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, BXPHF has a market cap of 392.2M. Regarding current trading prices, ADXSD is priced at $3.85, while BXPHF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas BXPHF's P/E ratio is -20.00. In terms of profitability, ADXSD's ROE is +121.70%, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, ADXSD is more volatile compared to BXPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs NWBO Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, NWBO has a market cap of 388.4M. Regarding current trading prices, ADXSD is priced at $3.85, while NWBO trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas NWBO's P/E ratio is -4.49. In terms of profitability, ADXSD's ROE is +121.70%, compared to NWBO's ROE of +1.13%. Regarding short-term risk, ADXSD is more volatile compared to NWBO. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs CLVLF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, CLVLF has a market cap of 361.9M. Regarding current trading prices, ADXSD is priced at $3.85, while CLVLF trades at $7.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas CLVLF's P/E ratio is 14.44. In terms of profitability, ADXSD's ROE is +121.70%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, ADXSD is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs PRRUF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, PRRUF has a market cap of 322.9M. Regarding current trading prices, ADXSD is priced at $3.85, while PRRUF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas PRRUF's P/E ratio is -11.05. In terms of profitability, ADXSD's ROE is +121.70%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, ADXSD is more volatile compared to PRRUF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs CLVLY Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, CLVLY has a market cap of 322.3M. Regarding current trading prices, ADXSD is priced at $3.85, while CLVLY trades at $6.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas CLVLY's P/E ratio is 12.86. In terms of profitability, ADXSD's ROE is +121.70%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, ADXSD is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs HLOSF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, HLOSF has a market cap of 321.6M. Regarding current trading prices, ADXSD is priced at $3.85, while HLOSF trades at $3.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas HLOSF's P/E ratio is -10.23. In terms of profitability, ADXSD's ROE is +121.70%, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, ADXSD is more volatile compared to HLOSF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs PBBIF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, ADXSD is priced at $3.85, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, ADXSD's ROE is +121.70%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, ADXSD is less volatile compared to PBBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs GNFTF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, GNFTF has a market cap of 276.3M. Regarding current trading prices, ADXSD is priced at $3.85, while GNFTF trades at $5.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas GNFTF's P/E ratio is 13.87. In terms of profitability, ADXSD's ROE is +121.70%, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, ADXSD is more volatile compared to GNFTF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs IPHYF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, IPHYF has a market cap of 267.3M. Regarding current trading prices, ADXSD is priced at $3.85, while IPHYF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas IPHYF's P/E ratio is -4.14. In terms of profitability, ADXSD's ROE is +121.70%, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, ADXSD is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs TRGNF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, TRGNF has a market cap of 263.9M. Regarding current trading prices, ADXSD is priced at $3.85, while TRGNF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas TRGNF's P/E ratio is -6.06. In terms of profitability, ADXSD's ROE is +121.70%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, ADXSD is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs AVCTF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, AVCTF has a market cap of 241M. Regarding current trading prices, ADXSD is priced at $3.85, while AVCTF trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas AVCTF's P/E ratio is -5.19. In terms of profitability, ADXSD's ROE is +121.70%, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, ADXSD is more volatile compared to AVCTF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs OPORF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, OPORF has a market cap of 240.5M. Regarding current trading prices, ADXSD is priced at $3.85, while OPORF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas OPORF's P/E ratio is 17.50. In terms of profitability, ADXSD's ROE is +121.70%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, ADXSD is more volatile compared to OPORF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs ORYZF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, ORYZF has a market cap of 234.9M. Regarding current trading prices, ADXSD is priced at $3.85, while ORYZF trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas ORYZF's P/E ratio is -43.29. In terms of profitability, ADXSD's ROE is +121.70%, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, ADXSD is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs NWPHF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, NWPHF has a market cap of 231.2M. Regarding current trading prices, ADXSD is priced at $3.85, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas NWPHF's P/E ratio is N/A. In terms of profitability, ADXSD's ROE is +121.70%, compared to NWPHF's ROE of N/A. Regarding short-term risk, ADXSD is more volatile compared to NWPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs HNSBF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, HNSBF has a market cap of 223.8M. Regarding current trading prices, ADXSD is priced at $3.85, while HNSBF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas HNSBF's P/E ratio is -2.58. In terms of profitability, ADXSD's ROE is +121.70%, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, ADXSD is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs BSEM Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, BSEM has a market cap of 216.2M. Regarding current trading prices, ADXSD is priced at $3.85, while BSEM trades at $13.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas BSEM's P/E ratio is -23.21. In terms of profitability, ADXSD's ROE is +121.70%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, ADXSD is more volatile compared to BSEM. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs SLNCF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, SLNCF has a market cap of 212.5M. Regarding current trading prices, ADXSD is priced at $3.85, while SLNCF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas SLNCF's P/E ratio is -2.94. In terms of profitability, ADXSD's ROE is +121.70%, compared to SLNCF's ROE of -0.87%. Regarding short-term risk, ADXSD is more volatile compared to SLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs SPHDF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, SPHDF has a market cap of 211.9M. Regarding current trading prices, ADXSD is priced at $3.85, while SPHDF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas SPHDF's P/E ratio is -3.65. In terms of profitability, ADXSD's ROE is +121.70%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, ADXSD is more volatile compared to SPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs FPHAF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, ADXSD is priced at $3.85, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, ADXSD's ROE is +121.70%, compared to FPHAF's ROE of N/A. Regarding short-term risk, ADXSD is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs VSBC Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, VSBC has a market cap of 207M. Regarding current trading prices, ADXSD is priced at $3.85, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas VSBC's P/E ratio is N/A. In terms of profitability, ADXSD's ROE is +121.70%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, ADXSD is more volatile compared to VSBC. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs FGHQF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, FGHQF has a market cap of 205.6M. Regarding current trading prices, ADXSD is priced at $3.85, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, ADXSD's ROE is +121.70%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, ADXSD is less volatile compared to FGHQF. This indicates potentially lower risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs AMGXF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, AMGXF has a market cap of 190.7M. Regarding current trading prices, ADXSD is priced at $3.85, while AMGXF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas AMGXF's P/E ratio is -0.69. In terms of profitability, ADXSD's ROE is +121.70%, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, ADXSD is more volatile compared to AMGXF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs BRIBF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, BRIBF has a market cap of 190.3M. Regarding current trading prices, ADXSD is priced at $3.85, while BRIBF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas BRIBF's P/E ratio is -2.60. In terms of profitability, ADXSD's ROE is +121.70%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, ADXSD is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs NGENF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, NGENF has a market cap of 189.6M. Regarding current trading prices, ADXSD is priced at $3.85, while NGENF trades at $2.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas NGENF's P/E ratio is -9.32. In terms of profitability, ADXSD's ROE is +121.70%, compared to NGENF's ROE of -2.23%. Regarding short-term risk, ADXSD is more volatile compared to NGENF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs CMVLF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, CMVLF has a market cap of 187.4M. Regarding current trading prices, ADXSD is priced at $3.85, while CMVLF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas CMVLF's P/E ratio is -3.88. In terms of profitability, ADXSD's ROE is +121.70%, compared to CMVLF's ROE of -0.30%. Regarding short-term risk, ADXSD is less volatile compared to CMVLF. This indicates potentially lower risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs MLLCF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, MLLCF has a market cap of 155.6M. Regarding current trading prices, ADXSD is priced at $3.85, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas MLLCF's P/E ratio is -2.04. In terms of profitability, ADXSD's ROE is +121.70%, compared to MLLCF's ROE of -0.36%. Regarding short-term risk, ADXSD is more volatile compared to MLLCF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs SCNLF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, SCNLF has a market cap of 150.6M. Regarding current trading prices, ADXSD is priced at $3.85, while SCNLF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas SCNLF's P/E ratio is -4.84. In terms of profitability, ADXSD's ROE is +121.70%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, ADXSD is more volatile compared to SCNLF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs RECEF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, RECEF has a market cap of 144.2M. Regarding current trading prices, ADXSD is priced at $3.85, while RECEF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas RECEF's P/E ratio is -8.33. In terms of profitability, ADXSD's ROE is +121.70%, compared to RECEF's ROE of +2.26%. Regarding short-term risk, ADXSD is more volatile compared to RECEF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs PBIGF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, PBIGF has a market cap of 140.2M. Regarding current trading prices, ADXSD is priced at $3.85, while PBIGF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas PBIGF's P/E ratio is -12.00. In terms of profitability, ADXSD's ROE is +121.70%, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, ADXSD is more volatile compared to PBIGF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs HOFBF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, HOFBF has a market cap of 130.4M. Regarding current trading prices, ADXSD is priced at $3.85, while HOFBF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas HOFBF's P/E ratio is -11.00. In terms of profitability, ADXSD's ROE is +121.70%, compared to HOFBF's ROE of -1.07%. Regarding short-term risk, ADXSD is less volatile compared to HOFBF. This indicates potentially lower risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs AAPGV Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, ADXSD is priced at $3.85, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas AAPGV's P/E ratio is N/A. In terms of profitability, ADXSD's ROE is +121.70%, compared to AAPGV's ROE of N/A. Regarding short-term risk, ADXSD is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs PSTTF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, ADXSD is priced at $3.85, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, ADXSD's ROE is +121.70%, compared to PSTTF's ROE of N/A. Regarding short-term risk, ADXSD is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs EPRXF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, ADXSD is priced at $3.85, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, ADXSD's ROE is +121.70%, compared to EPRXF's ROE of -0.85%. Regarding short-term risk, ADXSD is more volatile compared to EPRXF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.
ADXSD vs BRAXF Comparison
ADXSD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXSD stands at 0. In comparison, BRAXF has a market cap of 104.1M. Regarding current trading prices, ADXSD is priced at $3.85, while BRAXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXSD currently has a P/E ratio of N/A, whereas BRAXF's P/E ratio is N/A. In terms of profitability, ADXSD's ROE is +121.70%, compared to BRAXF's ROE of -2.49%. Regarding short-term risk, ADXSD is more volatile compared to BRAXF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXSD.